SLC19A2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.551000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.077400E-01
Normal-vs-Stage2
5.078800E-01
Normal-vs-Stage3
6.428600E-01
Normal-vs-Stage4
3.681000E-01
Stage1-vs-Stage2
7.664000E-01
Stage1-vs-Stage3
2.577200E-01
Stage1-vs-Stage4
4.467400E-01
Stage2-vs-Stage3
2.376800E-01
Stage2-vs-Stage4
4.033600E-01
Stage3-vs-Stage4
2.848200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.416400E-01
Normal-vs-AfricanAmerican
5.108800E-01
Normal-vs-Asian
9.992200E-01
Caucasian-vs-AfricanAmerican
9.600400E-01
Caucasian-vs-Asian
7.777800E-02
AfricanAmerican-vs-Asian
2.929000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.146200E-01
Normal-vs-Female
4.900800E-01
Male-vs-Female
1.276190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.487400E-01
Normal-vs-Age(41-60Yrs)
3.930800E-01
Normal-vs-Age(61-80Yrs)
6.517000E-01
Normal-vs-Age(81-100Yrs)
5.016400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.604800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.111400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.648200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.647590E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.226200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.211000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.308200E-01
Normal-vs-Daily Drinker
6.521200E-01
Normal-vs-Weekly Drinker
6.701200E-01
Normal-vs-Occasional Drinker
6.974000E-01
Normal-vs-Social Drinker
5.091200E-01
Non Drinker-vs-Daily Drinker
9.096000E-01
Non Drinker-vs-Weekly Drinker
6.688400E-01
Non Drinker-vs-Occasional Drinker
8.492800E-01
Non Drinker-vs-Social Drinker
6.233000E-01
Daily Drinker-vs-Weekly Drinker
7.210800E-01
Daily Drinker-vs-Occasional Drinker
7.936600E-01
Daily Drinker-vs-Social Drinker
7.428800E-01
Weekly Drinker-vs-Occasional Drinker
6.106200E-01
Weekly Drinker-vs-Social Drinker
8.793600E-01
Occasional Drinker-vs-Social Drinker
5.461400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.377000E-01
Normal-vs-Grade 2
1.643580E-01
Normal-vs-Grade 3
5.742000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.425900E-02
Grade 1-vs-Grade 3
3.884400E-01
Grade 1-vs-Grade 4
2.377000E-01
Grade 2-vs-Grade 3
1.303400E-01
Grade 2-vs-Grade 4
1.643580E-01
Grade 3-vs-Grade 4
5.742000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.110000E-01
Normal-vs-NonDiabetic
6.296000E-01
Diabetic-vs-NonDiabetic
8.740000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.768600E-01
Normal-vs-NoPancreatitis
5.950600E-01
Pancreatitis-vs-NoPancreatitis
5.384600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.455200E-01
Normal-vs-N1
5.172000E-01
N0-vs-N1
1.515830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.462600E-01
Normal-vs-TP53-NonMutant
6.566600E-01
TP53-Mutant-vs-TP53-NonMutant
4.256800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
